Clinical Trials Directory

Trials / Completed

CompletedNCT03346512

Considerations on the Transfusion Threshold in Cardiac Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
852 (actual)
Sponsor
Pierre Wauthy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a retrospective observational study of the transfusion threshold in cardiac surgery. There is controversy in the literature regarding the transfusion threshold to be adopted, especially in a patient who has undergone cardiac surgery. Some authors suggest that the transfusion should be done in a restrictive way when a certain threshold in hemoglobin is reached, in order to avoid the risks it implies, especially infectious.This threshold is very controversial and remains to be defined (variations in the literature from 7g / dL to 9g / dL). Other authors conclude that there is no superiority of a restrictive transfusion compared to a more liberal transfusion, with regard to the morbidity or medical costs. It is therefore interesting to study, in a retrospective manner, the global and multidisciplinary management of patients who have undergone a cardiac surgery within the CHU Brugmann hospital, to analyze if they have been adequately transfused.

Conditions

Interventions

TypeNameDescription
PROCEDURECardiac surgeryCardiac surgery

Timeline

Start date
2016-02-01
Primary completion
2016-06-14
Completion
2016-06-14
First posted
2017-11-17
Last updated
2019-04-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03346512. Inclusion in this directory is not an endorsement.